BSD Medical Corporation (NASDAQ: BSDM) is pleased to announce that Oregon Health & Science University (OHSU) has acquired a BSD-500 Hyperthermia System (BSD-500). OHSU is a leading university that provides world-class treatment for the most complex health care needs. OHSU has been ranked in U.S. News & World Report's annual rankings as one of America's Best Hospitals for 15 consecutive years and has been recognized in the medical specialties of cancer and endocrinology. BSD is pleased that OHSU has added the BSD-500 to its world-renowned cancer treatment program.
“A Randomized Trial of Hyperthermia and Radiation for Superficial Tumors”
Oregon Health & Science University (OHSU) is one of more than 100 academic health centers in the United States. As an academic health center, OHSU offers comprehensive, cutting-edge patient care, has large research programs that explore new concepts, treatments and cures, and trains the healthcare professionals of the future. The OHSU School of Medicine faculty is recognized internationally for their pursuit of new knowledge in a breadth of investigative areas, including cancer. OHSU Healthcare provides leading-edge healthcare services to patients throughout the Pacific Northwest and beyond.
AI-powered tool predicts gene activity in cancer cells from biopsy images